Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Membranous Nephropathy”

149 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 149 results

Not applicableUnknownNCT05532111
What this trial is testing

Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial

Who this might be right for
Efficacy and Safety
RenJi Hospital 60
Not applicableLooking for participantsNCT03929887
What this trial is testing

KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis

Who this might be right for
Glomerular DiseaseMinimal Change DiseaseIgA Nephropathy+4 more
Seoul National University Hospital 3,000
Not applicableStudy completedNCT05428605
What this trial is testing

In Vitro Immunomodulation in Membranous Nephropathy Relapses

Who this might be right for
Extramembranous Glomerulopathy
Centre Hospitalier Universitaire de Nice 20
Not applicableLooking for participantsNCT06893328
What this trial is testing

A Real World Study About PMN

Who this might be right for
Primary Membranous Nephropathy
Wei Chen 200
Early research (Phase 1)Study completedNCT05314231
What this trial is testing

Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

Who this might be right for
Proteinuria
Alexion Pharmaceuticals, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT03285711
What this trial is testing

Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)

Who this might be right for
Lupus Membranous Nephropathy
Gilead Sciences 9
Testing effectiveness (Phase 2)Ended earlyNCT04154787
What this trial is testing

Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Novartis Pharmaceuticals 37
Large-scale testing (Phase 3)Study completedNCT01955187
What this trial is testing

Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy

Who this might be right for
MEMBRANOUS NEPHROPATHY
Hospital Universitario 12 de Octubre 86
Early research (Phase 1)Not Yet RecruitingNCT07234474
What this trial is testing

A Phase I Study of YK012 in Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Excyte Biopharma Ltd 66
Large-scale testing (Phase 3)Study completedNCT01180036
What this trial is testing

MEmbranous Nephropathy Trial Of Rituximab

Who this might be right for
Idiopathic Membranous Nephropathy
Mayo Clinic 130
Not applicableUnknownNCT05845762
What this trial is testing

Obinutuzumab in the Management of Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Qianfoshan Hospital 30
Post-approval studies (Phase 4)Looking for participantsNCT05839314
What this trial is testing

Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy

Who this might be right for
NephropathyGlomerular DiseasesIdiopathic Membranous Nephropathy
Chinese PLA General Hospital 480
Not applicableUnknownNCT05667909
What this trial is testing

Prognostic Model of Rituximab in the Treatment of MN

Who this might be right for
Idiopathic Membranous Nephropathy
Qianfoshan Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07765537
What this trial is testing

A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Shenzhen Fosun Kairos Biotechnology Co., Ltd. 55
Testing effectiveness (Phase 2)Ended earlyNCT04652570
What this trial is testing

Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Tenet Medicines 6
Not applicableUnknownNCT05667922
What this trial is testing

Prognostic Model of TAC in the Treatment of MN

Who this might be right for
Idiopathic Membranous Nephropathy
Qianfoshan Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT00977977
What this trial is testing

Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

Who this might be right for
Nephrotic SyndromeProteinuriaAutoimmune Disease+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Testing effectiveness (Phase 2)Study completedNCT04893096
What this trial is testing

MOR202 for Refractory MN

Who this might be right for
Membranous Nephropathy
Mario Negri Institute for Pharmacological Research 10
Early research (Phase 1)Looking for participantsNCT05668403
What this trial is testing

A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Shanghai Jiaolian Drug Research and Development Co., Ltd 52
Large-scale testing (Phase 3)WithdrawnNCT06120673
What this trial is testing

REmission in Membranous Nephropathy International Trial (REMIT)

Who this might be right for
Primary Membranous Nephropathy
The University of Queensland
Next Page